Rajesh P Karyakarte, Rashmita Das, Mansi V Rajmane, Sonali Dudhate, Jeanne Agarasen, Praveena Pillai, Priyanka M Chandankhede, Rutika S Labhshetwar, Yogita Gadiyal, Preeti P Kulkarni, Safanah Nizarudeen, Sushma Yanamandra, Nyabom Taji, Suvarna Joshi, Varsha Potdar
BACKGROUND: In August 2023, the BA.2.86 SARS-CoV-2 variant, with over 30 spike protein mutations, emerged amidst the global dominance of XBB sub-lineages. It evolved into JN.1 by late 2023, spreading across 71 countries. JN.1, distinct for its L455S mutation, significantly dominated global sequences, raising concerns over its transmission and clinical impact. The study investigates JN.1's clinical severity and its effect on hospital admissions in Maharashtra, India. METHODOLOGY: The present study involved 3,150 curated Indian SARS-CoV-2 whole genome sequences with collection dates between 1st August 2023 and 15th January 2024...
March 2024: Curēus